Step by Step


11/1/2016 - Medical Grand Rounds: COPD Year in Review





Credit Hours: CME 1.00

Target Audience:

Faculty, residents, fellows, and community physicians in General Internal Medicine and subspecialties.

Educational Objectives:

Upon completion of this activity, participants should be able to:

  • Recognize that lung function attained early in adulthood may impact the development of COPD later in life and that a wide range of lung function trajectories exist.
  • Appreciate that current and former smokers with symptoms but preserved pulmonary function have respiratory exacerbations, shorter walk distance, and evidence of subtle airway disease.
  • Describe the impact of a health coaching intervention on COPD readmission rates and outcomes
  • Describe how recent literature supports a clinical precision approach to selecting patients for bronchoscopic volume reduction.
  • Recognize that only a subset of COPD patients benefit from inhaled corticosteroids and to begin to select appropriate patients for treatment.

Suggested Additional Reading:

  1. Lange P et al. N Engl J Med 2015;373:111-122.
  2. Woodruff PG et al. N Engl J Med 2016;374:1811-1821.
  3. Mannino et al, Resp Med, Jan 2006.
  4. Shah et al. Chest 2015;147(5).
  5. Benzo et al. AJRCCM 2016; 194(6).
  6. Roberto Benzo; Kristin Vickers; Paul J. Novotny; Sharon Tucker; Johanna Hoult; Pamela Neuenfeldt; John Connett; Kate Lorig; Charlene McEvoy; Am J Respir Crit Care Med  194, 672-680. DOI: 10.1164/rccm.201512-2503OC.
  7. Magnussen et. al. NEJM 2014; 371:1285-1294.
  8. Watz et. al. The Lancet Respiratory Medicine 2016; 5:390–398.

Frank C. Sciurba, MD, FCCP — Associate Professor of Medicine Division of Pulmonary, Allergy and Critical Care Medicine Director, Emphysema Research Center Director, Pulmonary Function Exercise Physiology Laboratory
Dr. Sciurba receives grant/research support from Boehringer-Ingelheim Pharmaceuticals, Inc, GlaxoSmithKline, PneumRX, Inc., PulmonX. Dr. Sciurba is a consultant Boehringer-Ingelheim Pharmaceuticals, Inc., and GlaxoSmithKline.
Jessica Bon Field, MD, MS — Associate Program Director of Research, Internal Medicine Residency Director, Research Pathway Track Assistant Professor of Medicine Division of Pulmonary, Allergy and Critical Care Medicine
Dr. Bon receives grant/research support from Astra Zeneca.
No other members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

The University of Pittsburgh is an affirmative action, equal opportunity institution.